Research / DE / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-23-015380 General Corporate
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.92% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.26% · OPTIONAL · VALID
Share-count growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-4.58% · CORE · VALID
Revenue growth 45th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
12.05% · CORE · VALID
Inventory pressure 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
59.17% · OPTIONAL · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
22.25% · CORE · VALID
R&D intensity 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.34% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.37% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 44 states Self-history eligible
Aug 1, 2021 8/8 normalized Level 3 Oct 31, 2021 7/7 normalized Level 3 Jan 30, 2022 8/8 normalized Level 3 May 1, 2022 8/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 30, 2022 7/7 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Oct 29, 2023 7/7 normalized Level 3 Jan 28, 2024 7/7 normalized Level 3 Apr 28, 2024 7/7 normalized Level 3 Jul 28, 2024 7/7 normalized Level 3 Oct 27, 2024 7/7 normalized Level 3 Jan 26, 2025 7/7 normalized Level 3 Apr 27, 2025 7/7 normalized Level 3 Jul 27, 2025 7/7 normalized Level 3 Feb 1, 2026 7/7 normalized Level 3 May 3, 2026 7/7 normalized Level 3 Aug 2, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.55%
Current 1.92%
Delta 0.37% Cash Generation Increased
Previous 6.32%
Current 19.26%
Delta 12.94% Dilution Decreased
Previous -4.07%
Current -4.58%
Delta -0.51% Growth Decreased
Previous 30.04%
Current 12.05%
Delta -18.00% Inventory Pressure Increased
Previous 55.86%
Current 59.17%
Delta 3.31% Profitability Decreased
Previous 22.42%
Current 22.25%
Delta -0.17% R And D Intensity Increased
Previous 3.15%
Current 3.34%
Delta 0.20% Sbc Intensity Increased
Previous 0.18%
Current 0.37%
Delta 0.19% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.